HIPRA

Last updated

HIPRA is a biotech pharmaceutical company headquartered in Amer, Catalonia, Spain focused on prevention for animal and human health, with a product base of vaccines and diagnostic services. [1]

Contents

HIPRA has an international presence in 40 countries with its own subsidiaries, 3 R&D centres and production plants located in Europe (Spain) and America (Brazil). [2]

In addition, its international distribution network maintains open distribution channels with more than 100 countries, covering all 5 continents. [3]

Since 2020, the company has been developing a vaccine against COVID-19. [4]

History

HIPRA got founded in 1971, in a small laboratory in Madrid. [5] The name HIPRA comes from the surnames of its former creators: Hidalgo and Prada.

In 1991 HIPRA had a workforce of 100 people and a turnover of 10 million euros, it was an important year in HIPRA's history, with a new management team, and a redefined company expansion policy. [2]

In the year 2000, the company began internationalization, beginning the implementation of its own subsidiaries around the world. [5] Currently HIPRA has commercial subsidiaries in 40 countries. It also has 3 research centers and 6 production plants located in Europe and America. [2]

In 2009 HIPRA began to focus on prevention; therefore, it stopped investing in pharmacological products. [5]

In 2021 the new Human Health division was created by HIPRA to create new products. [6] The same year, GoodGut was acquired by HIPRA, a biotechnological start-up dedicated to the research and development of diagnostic tests for digestive diseases. [7]

In the wake of the Covid-19 pandemic, HIPRA decided to branch out from its traditional veterinary medicine market to develop the country's first Covid-19 vaccine. The vaccine developed by HIPRA is an adjuvanted recombinant protein vaccine based on a receptor-binding domain (RBD) fusion heterodimer containing the alpha and beta variants of SARS-CoV-2. [8]

In June 2022, the Generalitat of Catalonia awarded HIPRA the Creu de Sant Jordi for "its involvement in the research of a new vaccine against the disease caused by the SARS-CoV-2 virus" and for its "commitment to the country's public health." [9]

Animal health

HIPRA has developed more than 100 vaccines for different animal species, both production and companion animals, against a wide variety of biological targets. In addition to its Amer plant, the company has another plant in Brazil, in the Porto Alegre conurbation. It also has a university research centre in the United States. [10]

HIPRA's animal health products include vaccines, vaccination devices, [11] integrated traceability services and diagnostic kits.

References

  1. ↑ https://www.hipra.com/en/discover-hipra Retrieved 2024-01-08
  2. 1 2 3 https://www.hipra.com/en/history Retrieved 2024-01-08
  3. ↑ "Hipra". Parc Científic de Barcelona. 2020-10-20. Retrieved 2022-11-14.
  4. ↑ Limón, Raúl (2021-08-12). "First Spanish Covid-19 vaccine approved for human clinical trial". EL PAÍS English Edition. Retrieved 2021-11-05.
  5. 1 2 3 "La vacuna de Hipra crea más anticuerpos que la de Pfizer como dosis de refuerzo". La Vanguardia (in Spanish). 2022-03-15. Retrieved 2022-11-15.
  6. ↑ rumiNews (2020-12-14). "HIPRA da un paso firme hacia la salud humana con la vacuna frente a la Covid-19". Rumiantes el portal de rumiNews. Retrieved 2022-11-15.
  7. ↑ Bosch, Imma. "Hipra compra l'empresa Goodgut - 19 ago 2021". El Punt Avui (in Catalan). Retrieved 2022-11-15.
  8. ↑ "Avanza el ensayo clínico de la vacuna de HIPRA contra el COVID-19, con la administración de las". Clínic Barcelona (in Spanish). Retrieved 2025-07-23.
  9. ↑ "Creu de Sant Jordi a 20 personas y 10 entidades". gencat.cat (in European Spanish). Archived from the original on 2022-11-15. Retrieved 2025-07-23.
  10. ↑ "La vacuna de Hipra crea más anticuerpos que la de Pfizer como dosis de refuerzo". La Vanguardia (in Spanish). 2022-03-15. Retrieved 2022-11-18.
  11. ↑ Beek, Vincent ter (2016-06-24). "Hipra takes one step forward in Smart Vaccination". Pig Progress. Retrieved 2022-11-18.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.